| P2093 | author name string | Ana M. Gamero | |
| | Kevin P. Kotredes | |
| P2860 | cites work | Interferon lambda: a new sword in cancer immunotherapy | Q21296797 |
| | Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells | Q24291206 |
| | G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell | Q24293424 |
| | Involvement of Noxa in cellular apoptotic responses to interferon, double-stranded RNA, and virus infection | Q24294698 |
| | AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model | Q24301826 |
| | Mitochondrial localization and pro-apoptotic effects of the interferon-inducible protein ISG12a | Q24309131 |
| | The interferon stimulated gene 54 promotes apoptosis | Q24321910 |
| | INTERFEROME: the database of interferon regulated genes | Q24655279 |
| | Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics | Q24672792 |
| | Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1 | Q28190234 |
| | The interferon alpha induced protein ISG12 is localized to the nuclear membrane | Q28207604 |
| | Novel interferons | Q28218804 |
| | Synthesis in E. coli of a polypeptide with human leukocyte interferon activity | Q28276363 |
| | Rat inositol 1,4,5-trisphosphate 3-kinase C is enzymatically specialized for basal cellular inositol trisphosphate phosphorylation and shuttles actively between nucleus and cytoplasm | Q28565602 |
| | Cytokines tumor necrosis factor-α and interferon-γ induce pancreatic β-cell apoptosis through STAT1-mediated Bim protein activation | Q28579310 |
| | Interferon-resistant Daudi cell line with a Stat2 defect is resistant to apoptosis induced by chemotherapeutic agents | Q31083397 |
| | In silico identification of breast cancer genes by combined multiple high throughput analyses | Q33210801 |
| | STAT1 pathway mediates amplification of metastatic potential and resistance to therapy | Q33463332 |
| | Resistance to IFN-alpha-induced apoptosis is linked to a loss of STAT2 | Q33598823 |
| | Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma | Q33788697 |
| | TNFα cooperates with IFN-γ to repress Bcl-xL expression to sensitize metastatic colon carcinoma cells to TRAIL-mediated apoptosis | Q33802588 |
| | Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival | Q33997736 |
| | Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity | Q34163340 |
| | Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis | Q34277052 |
| | p53-mediated apoptosis requires inositol hexakisphosphate kinase-2 | Q34397020 |
| | Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients | Q34413764 |
| | IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis. | Q34461211 |
| | Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. | Q34537390 |
| | Interferons and apoptosis | Q35177498 |
| | IFNalpha/beta promotes cell survival by activating NF-kappa B | Q35570411 |
| | Systematic review of medical treatment in melanoma: current status and future prospects. | Q35584299 |
| | BID is a critical factor controlling cell viability regulated by IFN-α. | Q35621716 |
| | p204, a p200 family protein, as a multifunctional regulator of cell proliferation and differentiation | Q35641322 |
| | Control of type I interferon-induced cell death by Orai1-mediated calcium entry in T cells | Q35728237 |
| | The human interferon system: characterization and classification after discovery of novel members | Q35739714 |
| | A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis | Q35901899 |
| | G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells | Q35970888 |
| | Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens | Q35983931 |
| | STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells | Q36161667 |
| | Alternative signaling pathways regulating type I interferon-induced apoptosis. | Q36351980 |
| | Antibody targeted drugs as cancer therapeutics | Q36373103 |
| | HSP90 regulates cell survival via inositol hexakisphosphate kinase-2. | Q36446083 |
| | IP6K2 is a client for HSP90 and a target for cancer therapeutics development | Q36446267 |
| | Interferon-gamma (IFN-gamma) induces programmed cell death in differentiated human leukemic B cell lines | Q36726458 |
| | Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes | Q37206449 |
| | Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. | Q37246647 |
| | The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis. | Q37677795 |
| | Interferon-lambda as a potential therapeutic agent in cancer treatment | Q37774372 |
| | Emerging Roles of FAM14 Family Members (G1P3/ISG 6–16 and ISG12/IFI27) in Innate Immunity and Cancer | Q37799602 |
| | The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins | Q37821935 |
| | The multifaceted interferon-inducible p200 family proteins: from cell biology to human pathology. | Q37825491 |
| | Adjuvant therapy after curative treatment for hepatocellular carcinoma | Q37972807 |
| | MHC restricted and non-restricted killer lymphocytes | Q37997497 |
| | The JAK-STAT pathway at twenty | Q38004201 |
| | Adjuvant interferon alfa in malignant melanoma: an interdisciplinary and multinational expert review | Q38033002 |
| | NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation | Q39440633 |
| | Apoptosis induced by mammalian reovirus is beta interferon (IFN) independent and enhanced by IFN regulatory factor 3- and NF-κB-dependent expression of Noxa | Q39441853 |
| | miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells | Q39461411 |
| | Type I IFNs signaling and apoptosis resistance in glioblastoma cells. | Q39486541 |
| | Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomas | Q39497382 |
| | Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin. | Q39601803 |
| | Interferon-β induces apoptosis in human SH-SY5Y neuroblastoma cells through activation of JAK-STAT signaling and down-regulation of PI3K/Akt pathway | Q39636793 |
| | Activation of STAT1 is required for interferon-alpha-mediated cell death | Q39645745 |
| | Combinations of DNA Methyltransferase and Histone Deacetylase Inhibitors Induce DNA Damage in Small Cell Lung Cancer Cells: Correlation of Resistance with IFN-Stimulated Gene Expression | Q39672023 |
| | The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity | Q39701851 |
| | miR-21: an oncomir on strike in prostate cancer. | Q39749407 |
| | Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells | Q39788397 |
| | The human 1-8D gene (IFITM2) is a novel p53 independent pro-apoptotic gene. | Q39834950 |
| | Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. | Q39945284 |
| | The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. | Q39960772 |
| | Interferon induction in cancer: with some observations on the clinical effects of poly 1:C. | Q39998867 |
| | Targeting IFN-alpha to B cell lymphoma by a tumor-specific antibody elicits potent antitumor activities | Q40056860 |
| | Interferon alpha induces nucleus-independent apoptosis by activating extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase downstream of phosphatidylinositol 3-kinase and mammalian target of rapamycin | Q40066545 |
| | Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells. | Q40073614 |
| | Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer | Q40134000 |
| | Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. | Q40144504 |
| | PS-341 or a combination of arsenic trioxide and interferon-alpha inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells | Q40203795 |
| | Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines. | Q40224418 |
| | A preferential role for STAT5, not constitutively active STAT3, in promoting survival of a human lymphoid tumor | Q40224850 |
| | STAT5 contributes to interferon resistance of melanoma cells. | Q40372082 |
| | AKT activation and response to interferon-beta in human cancer cells | Q40406445 |
| | Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway | Q40571407 |
| | Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. | Q40798570 |
| | Vanadate facilitates interferon alpha-mediated apoptosis that is dependent on the Jak/Stat pathway | Q40817313 |
| | Identification of a novel conserved motif in the STAT family that is required for tyrosine phosphorylation | Q44727139 |
| | Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis | Q48112869 |
| | From RNase L to the multitalented p200 family proteins: an exploration of the modes of interferon action | Q48517504 |
| | The Role of p202 in Regulating Hematopoietic Cell Proliferation and Differentiation | Q57272458 |
| | Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts | Q60043706 |
| | Transcriptional induction by interferon. New protein(s) determine the extent and length of the induction | Q69982645 |
| | Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha | Q72131454 |
| | Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines | Q72134635 |
| | [Immunity and interference in vaccinia; inhibition of skin infection by inactivated virus] | Q73583847 |
| | [Research on viral interference] | Q74764800 |
| | Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells | Q82083946 |
| | Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa | Q83288649 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 162-70 | |
| P577 | publication date | 2013-04-01 | |
| P1433 | published in | Journal of Interferon and Cytokine Research | Q15754749 |
| P1476 | title | Interferons as inducers of apoptosis in malignant cells | |
| P478 | volume | 33 | |